麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

美國蘭瑟斯醫用品公司(Lantheus Medical)
Lantheus醫學影像公司?造影劑
?
Lantheus Medical Imaging is a worldwide leader in diagnostic medicine with 55 years dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The company’s proven success in discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease.

Lantheus imaging products include DEFINITY? Vial for (Perflutren Lipid Microsphere) Injectable Suspension, the leading ultrasound contrast agent used in ultrasound exams of the heart, also known as echocardiographic exams; ABLAVAR? (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease; Cardiolite? (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), a cardiac imaging agent that is the most successful radiopharmaceutical ever introduced and; TechneLite? (Technetium Tc99m Generator).

Lantheus has over 600 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia.

Mission

We create and provide pioneering medical imaging solutions to improve treatment of human disease.

Vision

To be the leading provider of innovative medical imaging solutions to improve human life.

A Proud Heritage

For more than half a century, Lantheus Medical Imaging, Inc. has helped physicians enhance patient care with its pioneering product portfolio that illuminates the heart and other organs. Formed in 1956 as New England Nuclear Corporation (NEN), the company grew to become a leader in the field of diagnostic imaging. In 1981, the company was purchased by E.I. du Pont de Nemours and Company. Bristol-Myers Squibb Company (BMS) subsequently acquired the diagnostic medical imaging business as part of its acquisition of DuPont Pharmaceuticals in 2001. In 2008, BMS Medical Imaging was acquired by Avista Capital Partners and formally re-launched as Lantheus Medical Imaging, operating again as an independent company.

?